Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Self-Efficacy for Coping with Cancer Enhances the Effect of Reiki Treatments During the Pre-Surgery Phase of Breast Cancer Patients.

Chirico A, D'Aiuto G, Penon A, Mallia L, DE Laurentiis M, Lucidi F, Botti G, Giordano A.

Anticancer Res. 2017 Jul;37(7):3657-3665.

PMID:
28668857
2.

A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA.

Esposito MV, Nunziato M, Starnone F, Telese A, Calabrese A, D'Aiuto G, Pucci P, D'Aiuto M, Baralle F, D'Argenio V, Salvatore F.

Int J Mol Sci. 2016 Dec 21;17(12). pii: E2145. doi: 10.3390/ijms17122145.

3.

The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.

D'Argenio V, Esposito MV, Telese A, Precone V, Starnone F, Nunziato M, Cantiello P, Iorio M, Evangelista E, D'Aiuto M, Calabrese A, Frisso G, D'Aiuto G, Salvatore F.

Clin Chim Acta. 2015 Jun 15;446:221-5. doi: 10.1016/j.cca.2015.03.045. Epub 2015 Apr 17.

4.

Anthropometric, metabolic and molecular determinants of human epidermal growth factor receptor 2 expression in luminal B breast cancer.

Vici P, Crispo A, Giordano A, Di Lauro L, Sperati F, Terrenato I, Pizzuti L, Sergi D, Mottolese M, Botti C, Grimaldi M, Capasso I, D'Aiuto G, Di Bonito M, Di Paola F, Maugeri-Saccà M, Montella M, Barba M.

J Cell Physiol. 2015 Aug;230(8):1708-12. doi: 10.1002/jcp.24891.

PMID:
25510909
5.

BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women.

Crispo A, Grimaldi M, D'Aiuto M, Rinaldo M, Capasso I, Amore A, D'Aiuto G, Giudice A, Ciliberto G, Montella M.

Breast. 2015 Feb;24(1):86-9. doi: 10.1016/j.breast.2014.11.005. Epub 2014 Nov 29.

PMID:
25466863
6.

Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype.

Capasso I, Esposito E, de Laurentiis M, Maurea N, Cavalcanti E, Botti G, Petrillo A, Montella M, D'Aiuto M, Coppola C, Crispo A, Grimaldi M, Frasci G, Fucito A, Ciliberto G, D'Aiuto G.

Diabetol Metab Syndr. 2014 Sep 26;6(1):105. doi: 10.1186/1758-5996-6-105. eCollection 2014.

7.

Breast cancer screening, body mass index and prognosis benefit.

Montella M, Grimaldi M, Rinaldo M, Capasso I, D' Aiuto M, D'Aiuto G, Ciliberto G, Crispo A.

J Med Screen. 2014 Sep;21(3):165-6. doi: 10.1177/0969141314547968. No abstract available.

PMID:
25150100
8.

Silicone lymphadenopathy: presentation of a further case containing asteroid bodies on fine-needle cytology sample.

Malzone MG, Campanile AC, Gioioso A, Fucito A, D'Aiuto G, Botti G, Fulciniti F.

Diagn Cytopathol. 2015 Jan;43(1):57-9. doi: 10.1002/dc.23123. Epub 2014 Jul 4.

PMID:
24995825
9.

Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial.

Capasso I, Esposito E, Maurea N, Montella M, Crispo A, De Laurentiis M, D'Aiuto M, Frasci G, Botti G, Grimaldi M, Cavalcanti E, Esposito G, Fucito A, Brillante G, D'Aiuto G, Ciliberto G.

Trials. 2013 Aug 28;14:273. doi: 10.1186/1745-6215-14-273.

10.

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study.

DeCensi A, Bonanni B, Maisonneuve P, Serrano D, Omodei U, Varricchio C, Cazzaniga M, Lazzeroni M, Rotmensz N, Santillo B, Sideri M, Cassano E, Belloni C, Muraca M, Segnan N, Masullo P, Costa A, Monti N, Vella A, Bisanti L, D'Aiuto G, Veronesi U; Italian HOT Study Group.

Ann Oncol. 2013 Nov;24(11):2753-60. doi: 10.1093/annonc/mdt244. Epub 2013 Jul 17.

PMID:
23864098
11.

High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.

Zurrida S, Bagnardi V, Curigliano G, Mastropasqua MG, Orecchia R, Disalvatore D, Greco M, Cataliotti L, D'Aiuto G, Talakhadze N, Goldhirsch A, Viale G.

Eur J Cancer. 2013 Oct;49(15):3083-92. doi: 10.1016/j.ejca.2013.05.007. Epub 2013 Jun 15.

PMID:
23777741
12.

Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience.

Capasso I, Esposito E, Pentimalli F, Montella M, Crispo A, Maurea N, D'Aiuto M, Fucito A, Grimaldi M, Cavalcanti E, Esposito G, Brillante G, Lodato S, Pedicini T, D'Aiuto G, Ciliberto G, Giordano A.

J Exp Clin Cancer Res. 2013 Mar 14;32:14. doi: 10.1186/1756-9966-32-14.

13.

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series.

Crispo A, Barba M, D'Aiuto G, De Laurentiis M, Grimaldi M, Rinaldo M, Caolo G, D'Aiuto M, Capasso I, Esposito E, Amore A, Di Bonito M, Botti G, Montella M.

BMC Cancer. 2013 Jan 10;13:15. doi: 10.1186/1471-2407-13-15.

14.

The dynamic optical breast imaging in the preoperative workflow of women with suspicious or malignant breast lesions: development of a new comprehensive score.

D'Aiuto M, Frasci G, Barretta ML, Gallipoli A, Ciuffo GM, Musco F, Orefice S, Frattini V, Guidi I, Siani C, Esposito E, Crispo A, Montella M, Chirico A, D'Aiuto G, Vecchione A.

ISRN Oncol. 2012;2012:631917. doi: 10.5402/2012/631917. Epub 2012 Sep 27.

15.

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.

Barba M, Sperati F, Stranges S, Carlomagno C, Nasti G, Iaffaioli V, Caolo G, Mottolese M, Botti G, Terrenato I, Vici P, Serpico D, Giordano A, D'Aiuto G, Crispo A, Montella M, Capurso G, Delle Fave G, Fuhrman B, Botti C, De Placido S.

Ann Oncol. 2012 Jul;23(7):1838-45. doi: 10.1093/annonc/mdr540. Epub 2011 Nov 18.

16.

Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial.

Nuzzo F, Morabito A, Gravina A, Di Rella F, Landi G, Pacilio C, Labonia V, Rossi E, De Maio E, Piccirillo MC, D'Aiuto G, Thomas R, Rinaldo M, Botti G, Di Bonito M, Di Maio M, Gallo C, Perrone F, de Matteis A.

BMC Cancer. 2011 Feb 16;11:75. doi: 10.1186/1471-2407-11-75.

17.

Surgery of the chest wall for involvement by breast cancer.

D'Aiuto M, Cicalese M, D'Aiuto G, Rocco G.

Thorac Surg Clin. 2010 Nov;20(4):509-17. doi: 10.1016/j.thorsurg.2010.09.001. Review.

PMID:
20974434
18.

Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience.

Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, Grimaldi M, De Marco M, Cavalcanti E, D'Aiuto M, Fucito A, Frasci G, Maurea N, Esposito G, Pedicini T, Vecchione A, D'Aiuto G, Giordano A.

Cancer Biol Ther. 2010 Dec 15;10(12):1240-3. Epub 2010 Dec 15.

PMID:
20935521
19.

Association between mode of breast cancer detection and diagnosis delay.

Crispo A, Montella M, Barba M, Schittulli F, De Marco MR, Grimaldi M, Quaranta M, Serravezza G, Savastano C, Botti G, La Vecchia C, D'Aiuto G.

Breast. 2009 Dec;18(6):382-6. doi: 10.1016/j.breast.2009.10.001. Epub 2009 Oct 30.

20.

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.

Frasci G, D'Aiuto G, Comella P, D'Aiuto M, Di Bonito M, Ruffolo P, Iodice G, Petrillo A, Lastoria S, Oliviero P, Capasso I, Montella M, Siani C, Santangelo M, Vizioli L, Comella G; Southern Italy Cooperative Oncology Group, Italy.

Ann Oncol. 2010 Apr;21(4):707-16. doi: 10.1093/annonc/mdp356. Epub 2009 Oct 8.

PMID:
19815652
21.

Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial.

Rossi E, Morabito A, Di Rella F, Esposito G, Gravina A, Labonia V, Landi G, Nuzzo F, Pacilio C, De Maio E, Di Maio M, Piccirillo MC, De Feo G, D'Aiuto G, Botti G, Chiodini P, Gallo C, Perrone F, de Matteis A.

J Clin Oncol. 2009 Jul 1;27(19):3192-7. doi: 10.1200/JCO.2008.18.6213. Epub 2009 Apr 20.

PMID:
19380451
22.

Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer.

Frasci G, Comella P, Rinaldo M, Iodice G, Di Bonito M, D'Aiuto M, Petrillo A, Lastoria S, Siani C, Comella G, D'Aiuto G.

Ann Oncol. 2009 Jul;20(7):1185-92. doi: 10.1093/annonc/mdn748. Epub 2009 Feb 13.

PMID:
19218307
23.

Outcome analysis of breast cancer patients receiving breast-conserving surgery in Southern Italy.

Frasci G, Crispo A, D'Aiuto G, Barba M, Rinaldo M, De Marco M, Grimaldi M, Capasso I, Botti G, Di Bonito M, Montella M.

J Chemother. 2008 Apr;20(2):269-77.

PMID:
18467256
24.

Gail model risk factors: impact of adding an extended family history for breast cancer.

Crispo A, D'Aiuto G, De Marco M, Rinaldo M, Grimaldi M, Capasso I, Amore A, Bosetti C, La Vecchia C, Montella M.

Breast J. 2008 May-Jun;14(3):221-7. doi: 10.1111/j.1524-4741.2008.00566.x. Epub 2008 Mar 26.

PMID:
18373641
25.

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.

Nuzzo F, Morabito A, De Maio E, Di Rella F, Gravina A, Labonia V, Landi G, Pacilio C, Piccirillo MC, Rossi E, D'Aiuto G, Thomas R, Gori S, Colozza M, De Placido S, Lauria R, Signoriello G, Gallo C, Perrone F, de Matteis A.

Crit Rev Oncol Hematol. 2008 May;66(2):171-80. Epub 2007 Dec 21.

PMID:
18160303
26.

Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.

Rossi E, Morabito A, De Maio E, Di Rella F, Esposito G, Gravina A, Labonia V, Landi G, Nuzzo F, Pacilio C, Piccirillo MC, D'Aiuto G, D'Aiuto M, Rinaldo M, Botti G, Gallo C, Perrone F, de Matteis A.

J Clin Oncol. 2008 Jan 10;26(2):264-70. Epub 2007 Dec 17.

PMID:
18086795
27.

Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.

Veronesi U, Maisonneuve P, Rotmensz N, Bonanni B, Boyle P, Viale G, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Oliviero P, Lovison F, Gucciardo G, del Turco MR, Muraca MG, Pizzichetta MA, Conforti S, Decensi A; Italian Tamoxifen Study Group.

J Natl Cancer Inst. 2007 May 2;99(9):727-37.

PMID:
17470740
28.

Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.

De Maio E, Pacilio C, Gravina A, Morabito A, Di Rella F, Labonia V, Landi G, Nuzzo F, Rossi E, Silvestro P, Botti G, Di Bonito M, Curcio MP, Formichelli F, La Vecchia F, Staiano M, Maurea N, D'Aiuto G, D'Aiuto M, Thomas R, Signoriello G, Perrone F, de Matteis A.

BMC Cancer. 2007 Mar 20;7:50.

29.

Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.

Macis D, Maisonneuve P, Johansson H, Bonanni B, Botteri E, Iodice S, Santillo B, Penco S, Gucciardo G, D'Aiuto G, Rosselli Del Turco M, Amadori M, Costa A, Decensi A.

Breast Cancer Res Treat. 2007 Dec;106(2):263-71. Epub 2007 Jan 27.

PMID:
17260091
30.

FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders.

Chiappetta G, Ferraro A, Botti G, Monaco M, Pasquinelli R, Vuttariello E, Arnaldi L, Di Bonito M, D'Aiuto G, Pierantoni GM, Fusco A.

BMC Cancer. 2007 Jan 25;7:17.

31.

Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study.

Frasci G, D'Aiuto G, Comella P, Thomas R, Botti G, Di Bonito M, De Rosa V, Iodice G, Rubulotta MR, Comella G; Southern Italy Cooperative Oncology Group (SICOG).

Br J Cancer. 2006 Oct 23;95(8):1005-12.

32.

Identification of cripto-1 as a novel serologic marker for breast and colon cancer.

Bianco C, Strizzi L, Mancino M, Rehman A, Hamada S, Watanabe K, De Luca A, Jones B, Balogh G, Russo J, Mailo D, Palaia R, D'Aiuto G, Botti G, Perrone F, Salomon DS, Normanno N.

Clin Cancer Res. 2006 Sep 1;12(17):5158-64.

33.

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial.

Pacilio C, Morabito A, Nuzzo F, Gravina A, Labonia V, Landi G, Rossi E, De Maio E, Di Maio M, D'Aiuto G, Botti G, Normanno N, Chiodini P, Gallo C, Perrone F, de Matteis A; NCI-Naples Breast Cancer Group.

Br J Cancer. 2006 May 8;94(9):1233-6.

34.

Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients.

Frasci G, D'Aiuto G, Thomas R, Comella P, Di Bonito M, Lapenta L, D'Aiuto M, Botti G, Vallone P, De Rosa V, D'Aniello R, Giordano R, Comella G.

Oncology. 2005;68(4-6):391-7. Epub 2005 Jul 12.

PMID:
16020968
35.

A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study.

Frasci G, D'Aiuto G, Comella P, Thomas R, Botti G, Di Bonito M, D'Aiuto M, Romano G, Rubulotta MR, Comella G.

Ann Oncol. 2005 Aug;16(8):1268-75. Epub 2005 Jun 3.

PMID:
15937055
36.

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience.

De Maio E, Gravina A, Pacilio C, Amabile G, Labonia V, Landi G, Nuzzo F, Rossi E, D'Aiuto G, Capasso I, Rinaldo M, Morrica B, Elmo M, Di Maio M, Perrone F, de Matteis A.

BMC Cancer. 2005 Mar 24;5:30.

37.

Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.

Decensi A, Maisonneuve P, Rotmensz N, Bettega D, Costa A, Sacchini V, Salvioni A, Travaglini R, Oliviero P, D'Aiuto G, Gulisano M, Gucciardo G, del Turco MR, Pizzichetta MA, Conforti S, Bonanni B, Boyle P, Veronesi U; Italian Tamoxifen Study Group.

Circulation. 2005 Feb 8;111(5):650-6.

PMID:
15699284
38.

Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy.

Veronesi U, Orecchia R, Zurrida S, Galimberti V, Luini A, Veronesi P, Gatti G, D'Aiuto G, Cataliotti L, Paolucci R, Piccolo P, Massaioli N, Sismondi P, Rulli A, Lo Sardo F, Recalcati A, Terribile D, Acerbi A, Rotmensz N, Maisonneuve P.

Ann Oncol. 2005 Mar;16(3):383-8. Epub 2005 Jan 24.

PMID:
15668261
39.

HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression.

Chiappetta G, Botti G, Monaco M, Pasquinelli R, Pentimalli F, Di Bonito M, D'Aiuto G, Fedele M, Iuliano R, Palmieri EA, Pierantoni GM, Giancotti V, Fusco A.

Clin Cancer Res. 2004 Nov 15;10(22):7637-44.

40.

Inequalities in the healthcare system and breast cancer survival.

Montella M, Crispo A, D'Aiuto G.

Int J Cancer. 2004 Mar;109(1):153-4. No abstract available.

41.

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study.

Frasci G, Comella P, Thomas R, Di Bonito M, Lapenta L, Capasso I, Botti G, Vallone P, De Rosa V, D'Aiuto G, Comella G.

Cancer Chemother Pharmacol. 2004 Jan;53(1):25-32. Epub 2003 Sep 26.

PMID:
14513281
42.

Difference in breast cancer stage, treatment, and survival.

Montella M, Crispo A, D'Aiuto G.

Arch Intern Med. 2003 May 26;163(10):1241-2. No abstract available.

PMID:
12767968
43.

Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.

Rossi E, Perrone F, Labonia V, Landi G, Nuzzo F, Amabile G, Gridelli C, Di Maio M, D'Aiuto G, de Matteis A.

Oncology. 2003;64(4):479-80. No abstract available.

PMID:
12759551
44.

Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.

Veronesi U, Maisonneuve P, Rotmensz N, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Lovison F, Gucciardo G, Muraca MG, Pizzichetta MA, Conforti S, Decensi A, Robertson C, Boyle P; Italian Tamoxifen Study Group.

J Natl Cancer Inst. 2003 Jan 15;95(2):160-5.

PMID:
12529349
45.

Re: delay in breast cancer: a prevention dilemma.

Montella M, Crispo A, Comella G, D'Aiuto G.

Prev Med. 2002 Dec;35(6):616-7. No abstract available.

PMID:
12460530
46.

Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma.

Montella M, Crispo A, D'Aiuto G.

Cancer. 2002 Nov 15;95(10):2254-5; author reply 2255. No abstract available.

47.

Rationale for a study adding tamoxifen to HRT.

Rotmensz N, Decensi A, Maisonneuve P, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Lovison F, Gucciardo G, Muraca MG, Pizzichetta MA, Conforti S, Robertson C, Boyle P, Veronesi U.

Eur J Cancer. 2002 Nov;38 Suppl 6:S22-3. No abstract available.

PMID:
12409061
48.

Immediate breast reconstruction with the transverse rectus abdominis musculocutaneous flap after skin-sparing mastectomy.

Gherardini G, Thomas R, Basoccu G, Zaccheddu R, Fortunato L, Cortino P, Evans GR, Matarasso A, D'Aiuto M, D'Aiuto G.

Int Surg. 2001 Oct-Dec;86(4):246-51.

PMID:
12056470
49.

Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.

Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M.

Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):809-14. Epub 2002 Mar 13.

PMID:
12029556
50.

Intragenic amplification and formation of extrachromosomal small circular DNA molecules from the PIP gene on chromosome 7 in primary breast carcinomas.

Autiero M, Camarca A, Ciullo M, Debily MA, El Marhomy S, Pasquinelli R, Capasso I, D'Aiuto G, Anzisi AM, Piatier-Tonneau D, Guardiola J.

Int J Cancer. 2002 May 20;99(3):370-7.

Supplemental Content

Loading ...
Support Center